Tocolytic therapy for preterm delivery: systematic review and network meta-analysis
DM Haas, DM Caldwell, P Kirkpatrick, JJ McIntosh… - Bmj, 2012 - bmj.com
Objective To determine the most effective tocolytic agent at delaying delivery. Design
Systematic review and network meta-analysis. Data sources Cochrane Central Register of …
Systematic review and network meta-analysis. Data sources Cochrane Central Register of …
Oxytocin: its mechanism of action and receptor signalling in the myometrium
S Arrowsmith, S Wray - Journal of neuroendocrinology, 2014 - Wiley Online Library
Oxytocin is a nonapeptide hormone that has a central role in the regulation of parturition and
lactation. In this review, we address oxytocin receptor (OTR) signalling and its role in the …
lactation. In this review, we address oxytocin receptor (OTR) signalling and its role in the …
Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth
JD Iams, R Romero, JF Culhane, RL Goldenberg - The lancet, 2008 - thelancet.com
Interventions to reduce the morbidity and mortality of preterm birth can be primary (directed
to all women), secondary (aimed at eliminating or reducing existing risk), or tertiary …
to all women), secondary (aimed at eliminating or reducing existing risk), or tertiary …
Calcium channel blockers for inhibiting preterm labour and birth
V Flenady, AM Wojcieszek… - Cochrane Database …, 2014 - cochranelibrary.com
Background Preterm birth is a major contributor to perinatal mortality and morbidity, affecting
around 9% of births in high‐income countries and an estimated 13% of births in low‐and …
around 9% of births in high‐income countries and an estimated 13% of births in low‐and …
Betamimetics for inhibiting preterm labour
JP Neilson, HM West… - Cochrane Database of …, 2014 - cochranelibrary.com
Background Preterm birth is a major contributor to perinatal mortality and morbidity
worldwide. Tocolytic agents are drugs used to inhibit uterine contractions. Betamimetics are …
worldwide. Tocolytic agents are drugs used to inhibit uterine contractions. Betamimetics are …
European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants–2010 update
Despite recent advances in the perinatal management of neonatal respiratory distress
syndrome (RDS), controversies still exist. We report the updated recommendations of a …
syndrome (RDS), controversies still exist. We report the updated recommendations of a …
Oxytocin: crossing the bridge between basic science and pharmacotherapy
C Viero, I Shibuya, N Kitamura… - CNS neuroscience & …, 2010 - Wiley Online Library
Is oxytocin the hormone of happiness? Probably not. However, this small nine amino acid
peptide is involved in a wide variety of physiological and pathological functions such as …
peptide is involved in a wide variety of physiological and pathological functions such as …
Prevention of preterm delivery
HN Simhan, SN Caritis - New England Journal of Medicine, 2007 - Mass Medical Soc
Although preterm birth (at< 37 weeks' gestation) is sometimes indicated for the health of the
mother or her fetus, spontaneous preterm births occur as a consequence of spontaneous …
mother or her fetus, spontaneous preterm births occur as a consequence of spontaneous …
Tocolytic therapy: a meta-analysis and decision analysis
DM Haas, AM Golichowski, TF Imperiale… - Obstetrics & …, 2009 - journals.lww.com
The authors have stressed that almost every pregnant woman is exposed to some type of
medication during pregnancy, and this issue has been observed in all countries. The …
medication during pregnancy, and this issue has been observed in all countries. The …
Oxytocin receptor antagonists for inhibiting preterm labour
V Flenady, HE Reinebrant, HG Liley… - Cochrane Database …, 2014 - cochranelibrary.com
Background Preterm birth, defined as birth between 20 and 36 completed weeks, is a major
contributor to perinatal morbidity and mortality globally. Oxytocin receptor antagonists …
contributor to perinatal morbidity and mortality globally. Oxytocin receptor antagonists …